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patients are dual scanned i.e. IV contrast 3D scan followed by 
non contrast 4DCT.  
Sixty five percent of centres agreed or strongly agreed 
updated guidelines would be useful. 
 
Conclusion: The results suggest adherence to RCR guidelines 
is poor. Very little current evidence exists relating to optimal 
IV contrast protocols both in the UK and internationally. No 
standardised guidelines exist in relation to 4DCT IV contrast 
protocols and timings which in some centres is resulting in 
patients being dual scanned. There are many areas such as 
flow rates, timings and administration in conjunction with 
advanced techniques which require further research to 
enable updated standardised guidelines to be identified. The 
need for updated guidelines is supported by 65% of 
respondents of this study. 
 
Poster Viewing: 8: Physics: Inter-fraction motion 
management II  
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Purpose or Objective: In image-guided radiotherapy (IGRT) 
for esophageal cancer, it is common to use bony anatomy-
based registration (BR) for setup verification. A recent study, 
in which we investigated fiducial marker-based registration 
relative to BR, indicated marker-based registration to be 
infeasible due to tissue deformation. In the present study, we 
investigated the feasibility and geometric accuracy of carina-
based registration (CR) for CBCT-guided setup verification in 
esophageal cancer IGRT. 
 
Material and Methods: Retrospectively, 24 esophageal 
cancer patients with 65 implanted fiducial markers, visible on 
planning CTs and follow-up CBCTs, were included in this 
study. Fiducial markers were considered as standard for 
tumor position. All available CBCT scans (n=236) were 
independently rigidly registered to the reference CT with 
respect to either the bony anatomy or to the carina using XVI 
software (Elekta Ltd. Crawley) to determine the individual 
marker displacement relative to the bony anatomy and to the 
carina, respectively. Automatic registrations were visually 
checked and manually adjusted when necessary. 
Subsequently, we assessed and compared per individual 
marker the mean marker displacement over the treatment 
course (systematic position error, SE) associated with either 
BR or CR. Markers were classified into four subgroups based 
on their locations in the esophagus (proximal, mid-esophagus, 
distal, cardia) and analysis was similarly as mentioned above 
performed per subgroup. Comparison between both 
registration methods was done using a paired Wilcoxon 
signed-rank test. 
 
Results: The distributions of the absolute mean systematic 
position error of the individual markers relative to the bony 
anatomy and the carina are given in Figure 1.A. Overall, a 
large SE is associated with the use of both bony anatomy and 
carina, especially in the CC direction. Figure 1.B, illustrates 
the slightly favorable use of the BR for proximal located 
markers. Markers located in the mid-esophagus show a 
smaller SE in CC and AP direction when using the CR, 
however this difference was not significant. For markers 
located in the distal esophagus and cardia, the BR is 
favorable in AP direction (p<0.001). Furthermore, the 
majority of the CRs were more challenging given the low 
contrast resolution in comparison with the BRs. 
 
 
 
 
Conclusion: The mean marker displacement (SE), residual 
tumor position error, over the treatment course remains 
large and is in most directions even slightly larger when using 
CR compared with BR. Only for tumors located in the mid-
esophagus the CR can be slightly favorable. However, 
esophageal tumors typically extend across regions and the 
majority of tumors are located distally. Therefore, our data 
endorse the use of BR over CR for setup verification. 
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Purpose or Objective: Contrast enhancement and respiration 
management are widely used during image acquisition for 
radiotherapy treatment planning of liver tumors along with 
respiration management at the treatment unit. However, 
neither respiration management nor intravenous contrast is 
commonly used during cone-beam CT (CBCT) image 
acquisition for alignment prior to radiotherapy. In this study, 
the authors investigate the potential gains of injecting an 
iodinated contrast agent in combination with respiration 
management during CBCT acquisition for liver tumor 
radiotherapy. 
 
Material and Methods: Five rabbits with implanted liver 
tumors were subjected to CBCT with and without motion 
management and contrast injection. The acquired CBCT 
images were registered to the planning CT to determine 
alignment accuracy and dosimetric impact. We developed a 
simulation tool for simulating contrast-enhanced CBCT 
images from dynamic contrast enhanced CT imaging (DCE-CT) 
to determine optimal contrast injection protocols. The tool 
was validated against contrast-enhanced CBCT of the rabbit 
subjects and was used for five human patients diagnosed with 
hepatocellular carcinoma. 
 
Results: In the rabbit experiment, when neither motion 
management nor contrast was used, tumor centroid 
misalignment between planning image and CBCT was 9.2 mm. 
This was reduced to 2.8 mm when both techniques were 
employed. Tumors were not visualized in clinical CBCT 
images of human subjects. Simulated contrast-enhanced 
CBCT was found to improve tumor contrast in all subjects. 
Different patients were found to require different contrast 
injection protocols to maximize tumor contrast. 
 
Conclusion: Localization of the tumor during treatment is the 
weak link in IGRT for liver. Respiration managed contrast 
enhanced CBCT provides a possible solution. Simulation tools 
for optimal contrast injection, recommended margins for 
interfraction motion and additional benefits from patient 
specific tracer kinetics determined from DCE-CT are 
presented. 
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Purpose or Objective: Bladder is a hollow and flexible organ 
exposed to high doses in RT for prostate cancer. Its absorbed 
dose can be properly described by the dose surface maps 
(DSM) however, due to its flexible nature, the discrepancy 
between the planned dose and the dose absorbed during the 
treatment is a major issue. Present work aims at verifying 
the robustness of DSMs relative to the daily inter-fraction 
movement of bladder during RT of prostate cancer. 
 
Material and Methods: 18 patients treated with moderately 
hypofractionated Tomotherapy were considered (prescription 
of 70 Gy at 2.5 Gy/fr in 28 fractions and full bladder). All 
patients underwent daily Image Guided Radiotherapy 
(through MVCT) with rigid registration on the prostate. After 
matching, bladder contours were delineated on each MVCT 
by a single observer and copied on the planning CT: the 
planned dose distribution was employed to generate DSMs. 
For each patient, the bladder DSMs from the planned 
treatment and from each fraction were then computed by 
unfolding the bladder contours on a 2D plane: they were 
anteriorly cut at the points intersecting the sagittal plane 
passing through the center of mass. The DSMs were then 
laterally normalized and aligned at the bladder base, while 
cranially they were cut at the minimal extension of the 
planned DSMs. Discrepancies between planned and treatment 
DSMs were analyzed through the average map of individual 
systematic errors, the map of population systematic errors 
(standard deviation of individual systematic errors) and that 
of population random errors (average of individual random 
errors) of dose. 
 
Results: 472 normalized DSM were considered (cranial 
extension 34 mm): the mean number of available daily MVCTs 
was 25 (18-28) per patient. The Figure shows the average 
planned map (panel A), the average map of individual 
systematic errors (B), the map of population systematic 
errors (C) and that of population random errors (D). Two 
main regions can be recognized: 1) the central posterior 
bladder base (light/dark blue in D) and 2) the region that 
surrounds it, involving the lateral and the more cranial 
portion of bladder (orange/red in D). Region 1), which 
absorbs the highest doses (see A), appears to be the most 
stable one during the treatment: panel B shows mean values 
between -1 Gy and 1 Gy in region 1) and around 2-3 Gy in 2). 
Population systematic (C) and random errors (D) are below 4 
and 3 Gy respectively in region 1), while they reach values 
between 6-11 Gy and 5-7 Gy, respectively, in 2). 
 
 
Conclusion: The results show that DSMs are quite stable with 
respect to changes occurring during daily IGRT for prostate 
cancer in the high-dose region, in the first 1-2 cm from 
bladder base. Larger systematic variations occur in the 
anterior portion and cranially 2.5-3.5cm from the base: these 
effects may be due to systematic differences in bladder 
filling and to systematic shits of bladder base between 
planning and treatment. 
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Purpose or Objective: To derive suitable CTV-PTV margins, 
using only anatomical information contained within cone 
